Industrials -
Consulting Services - NASDAQ - US
$ 78.94
-0.0639 %
$ 4.01 B
Market Cap
37.08
P/E
1. INTRINSIC VALUE
Balance Sheet
Exponent, Inc.
| Current Assets | 447 M |
| Cash & Short-Term Investments | 259 M |
| Receivables | 161 M |
| Other Current Assets | 26.6 M |
| Non-Current Assets | 330 M |
| Long-Term Investments | 0 |
| PP&E | 148 M |
| Other Non-Current Assets | 182 M |
| Current Liabilities | 163 M |
| Accounts Payable | 5.27 M |
| Short-Term Debt | 5.39 M |
| Other Current Liabilities | 153 M |
| Non-Current Liabilities | 193 M |
| Long-Term Debt | 76.1 M |
| Other Non-Current Liabilities | 117 M |
EFFICIENCY
Earnings Waterfall
Exponent, Inc.
| Revenue | 559 M |
| Cost Of Revenue | 0 |
| Gross Profit | 559 M |
| Operating Expenses | 439 M |
| Operating Income | 120 M |
| Other Expenses | 10.6 M |
| Net Income | 109 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Exponent, Inc.
| Net Income | 109 M |
| Depreciation & Amortization | 9.69 M |
| Capital Expenditures | -6.94 M |
| Stock-Based Compensation | 23.2 M |
| Change in Working Capital | 1.46 M |
| Others | 3.97 M |
| Free Cash Flow | 138 M |
Wall Street Analysts Price Targets
Exponent, Inc.
Wall Street analysts predict an average 1-year price target for EXPO of $104 , with forecasts ranging from
a
low of
$88 to a high of $120 .
EXPO Lowest Price Target
Wall Street Target
88 USD
11.48%
EXPO Average Price Target
Wall Street Target
104 USD
31.75%
EXPO Highest Price Target
Wall Street Target
120 USD
52.01%
4. DIVIDEND
ANALYSIS
0.31%
DIVIDEND YIELD
0.3 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Exponent, Inc.
Sold
0-3 MONTHS
149 K USD 1
3-6 MONTHS
2.64 M USD 2
6-9 MONTHS
11.3 M USD 4
9-12 MONTHS
5.87 M USD 4
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Exponent to Announce First Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on May 1, 2025
MENLO PARK, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2025 financial results for the period ended April 4, 2025 following the close of the market on Thursday, May 1, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
globenewswire.com
- 3 weeks ago
Paysign, Inc. to Present at the Ladenburg Thalmann Technology Innovation EXPO25
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Ladenburg Thalmann Technology Innovation EXPO25.
businesswire.com
- 3 weeks ago
Exponent: A Unique Dividend Contender That Is Valued At A Premium
Exponent Inc. is a market leader in scientific and engineering consulting, with a 13-year dividend growth streak and a solid balance sheet. Despite strong revenue and earnings growth, the valuation is at a premium, making Exponent a hold. The company's competitive advantages include its reputation, technical expertise, and long-term client relationships, ensuring continued market leadership.
seekingalpha.com
- 1 month ago
31 Upcoming Dividend Increases, Including 3 Kings
This week sees 31 dividend increases, including three Dividend Kings: Genuine Parts, Commerce Bancshares, and Kimberly-Clark, showcasing impressive financial stability and growth. My investment strategy prioritizes companies with consistently rising dividends and outperforming benchmarks, aiming for long-term wealth accumulation and portfolio prosperity. I use data from the "U.S. Dividend Champions" spreadsheet and NASDAQ to identify companies with at least five years of dividend growth.
seekingalpha.com
- 2 months ago
New Strong Sell Stocks for February 27th
CAT, CABGY and EXPO have been added to the Zacks Rank #5 (Strong Sell) List on February 27, 2025.
zacks.com
- 2 months ago
Exponent, Inc. (EXPO) Q4 2024 Earnings Call Transcript
Exponent, Inc. (NASDAQ:EXPO ) Q4 2024 Earnings Conference Call February 6, 2024 4:30 PM ET Company Participants Joni Konstantelos - MD, Riveron Consulting Catherine Corrigan - President and CEO Rich Schlenker - EVP and CFO Conference Call Participants Andrew Nicholas - William Blair Tobey Sommer - Truist Josh Chan - UBS Operator Good day, and welcome to the Exponent, Inc. Q4 2024 Earnings Conference Call. All participants will be in listen-only mode.
seekingalpha.com
- 2 months ago
Exponent (EXPO) Q4 Earnings and Revenues Top Estimates
Exponent (EXPO) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.41 per share a year ago.
zacks.com
- 2 months ago
Baron Small Cap Fund: Q4 2024 Top Contributors And Detractors
Vertiv Holdings Co. excels with strong AI-related data center demand, projecting 16%-18% organic revenue growth for 2025, and increased profit margins. Chart Industries, Inc. shows robust fundamentals with record revenue and margins, expecting 12% revenue and 18% EBITDA growth in 2025. Intapp, Inc. benefits from strong quarterly results, 17% revenue growth, and a record pipeline, driven by AI product demand and favorable M&A activity.
seekingalpha.com
- 3 months ago
Exponent to Announce Fourth Quarter and Fiscal Year 2024 Results and Host Quarterly Conference Call on February 6, 2025
MENLO PARK, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Fourth Quarter and fiscal year 2024 financial results for the period ended January 3, 2025 following the close of the market on Thursday, February 6, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.
globenewswire.com
- 3 months ago
3 Stocks to Buy From the Prosperous Consulting Services Industry
The Zacks Consulting Services industry is poised to prosper, with service activities remaining healthy. IT, STN and EXPO are three stocks that are well-placed to ride the demand strength.
zacks.com
- 6 months ago
Exponent, Inc. (EXPO) Q3 2024 Earnings Call Transcript
Exponent, Inc. (NASDAQ:EXPO ) Q3 2024 Earnings Conference Call October 24, 2024 4:30 PM ET Company Participants Joni Konstantelos - Managing Director of Riveron Consulting Catherine Corrigan - President and Chief Executive Officer Rich Schlenker - Executive Vice President and Chief Financial Officer Conference Call Participants Jasper Bibb - Truist Securities, Inc. Andrew Nicholas - William Blair & Company L.L.C. Joshua Chan - UBS Investment Bank Operator Good afternoon, everyone, and welcome to the Exponent, Inc. Q3 2024 Earnings Conference Call.
seekingalpha.com
- 6 months ago
Exponent (EXPO) Q3 Earnings Top Estimates
Exponent (EXPO) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.48 per share a year ago.
zacks.com
- 6 months ago
8. Profile
Summary
Exponent, Inc. EXPO
COUNTRY
US
INDUSTRY
Consulting Services
MARKET CAP
$ 4.01 B
Dividend Yield
0.31%
Description
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Contact
149 Commonwealth Drive, Menlo Park, CA, 94025
https://www.exponent.com
IPO
Date
Aug. 17, 1990
Employees
1168
Officers
Dr. Subbaiah V. Malladi P.E., Ph.D.
Chief Technology Officer & Principal Engineer
Dr. Bernard Ross P.E., Ph.D.
Co-Founder, Chairman Emeritus & Principal Engineer
Ms. Akiyo Toba
Controller
Mr. Richard L. Schlenker Jr.
Executive Vice President, Chief Financial Officer & Corporate Secretary
Mr. Eric R. Anderson
Vice President of Finance & Accounting
Dr. Catherine Ford Corrigan P.E., Ph.D.
President, Chief Executive Officer & Director
Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D.
Group Vice President
Dr. Joseph Rakow Ph.D.
Group Vice President
Ms. Gina Flynn
Vice President of Legal & General Counsel
Mr. Brian Kundert
Chief Human Resources Officer